Polansky's AI on Human Skin Raises Ethical Concerns
· anime
The Skin Deep Truth: Polansky’s Ambitious AI Project Raises Questions About Human Tissue and Consent
Michael Polansky’s unassuming demeanor belies his high-profile life as a business partner to Lady Gaga. As the founder of Outer Biosciences, he has made headlines for training an AI model on skin that is still alive – a remarkable achievement with significant implications for our understanding of human tissue and consent.
Polansky’s entry into life sciences was facilitated by his connections to Sean Parker’s network. However, it was his time at the Parker Institute for Cancer Immunotherapy that laid the groundwork for Outer Biosciences. The company focuses on using discarded human skin for experimentation in response to the limitations of current methods in biology and chemistry – namely, the lack of an ethical way to run experiments directly on people.
The sourcing of human tissue through non-profit and commercial biobanks and brokers raises complex questions about consent. Polansky assures that every sample arrives de-identified, but this does not address the question of who these donors are and what they know about their tissues being used for AI training. The fact that Outer Biosciences pays fees to suppliers on a cost-recovery basis rather than purchasing tissue outright is a crucial distinction – it implies that Polansky’s company is creating a market for human tissue, not just exploiting existing medical waste.
This development should give us pause. We have grown accustomed to the idea of companies collecting our personal data without our explicit consent. But what about our bodily tissues? Are they fair game for exploitation in the name of progress? Polansky’s project exemplifies the “dark pattern” of medical innovation, where human subjects are unwittingly enrolled in experiments without their full knowledge or understanding.
The implications of this technology extend far beyond AI research. What does it mean for our bodies to be treated as disposable commodities? How will this shape our relationships with healthcare and the medical establishment? The intersection of medicine and tech is fraught, and we must consider the consequences of treating human tissue like mere raw material.
As Polansky’s work continues to push the boundaries of what’s possible in AI research, it’s essential that we scrutinize the ethics behind it. We owe it to ourselves, our bodies, and those who have contributed their tissues without full understanding or consent.
Reader Views
- MPMira P. · comics critic
The lucrative market for human tissue is finally getting the scrutiny it deserves, and Polansky's AI on human skin project is a prime example of how corporate interests can hijack advances in biotech. What's striking is that this development isn't just about the ethics of consent – it also raises questions about what kind of control we have over our own bodily byproducts. As medical waste becomes a commodity, who exactly benefits from its exploitation? We need to think critically not only about how our data is being used but also about whose interests are being served when it comes to human tissue.
- TIThe Ink Desk · editorial
The convenience of de-identified samples is precisely the problem: by stripping individuals of their agency over their own bodies, Polansky's project sidesteps crucial conversations about what truly constitutes consent in medical research. What's needed now is a closer examination of how this commodification of human tissue will be regulated, and whether existing frameworks for data protection can be adapted to safeguard bodily autonomy.
- KAKenji A. · longtime fan
Polansky's reliance on cost-recovery fees from suppliers rather than purchasing tissue outright raises more questions about his company's intentions and accountability. It's unlikely that every donor is truly de-identified, especially considering how interconnected biobank networks can be. Without clear transparency on sourcing and donor consent, Outer Biosciences' business model seems to prioritize profit over the ethics of using human tissues in AI training. How will they ensure that donors are fully informed about their contributions, and what happens if their identities are accidentally or intentionally linked?